Strides arm and its partner get USFDA nod for hypokalemia treatment drug
Posted by
www.biotecnika.org
The approved product, used in treatment of patients with hypokalemia,
is a generic version of Merck, Inc's Potassium Chloride
extended-release tablets, a regulatory filing said.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-arm-and-its-partner-get-usfda-nod-for-hypokalemia-treatment-drug/articleshow/68684023.cms
Subscribe to:
Post Comments (Atom)
Post a Comment